Elapsed time changes of the brain radiopharmaceutical accumulation of the amyloid PET examination using 18F-flutemetamol
Annals of Nuclear Medicine · 2025
DOI: 10.1007/s12149-025-02046-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Nuclear Medicine, 2025. Verfasst von Shota Takemoto und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Juntendo University Hospital, 3‑1‑3, Hongo, Bunkyo‑ku, Tokyo, 113‑8421, Japan. stakemot@juntendo.ac.jp. Hauptthemen laut MEDLINE: Brain, Positron-Emission Tomography, Radiopharmaceuticals, Aniline Compounds. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nihon Medi-Physics.
Abstract (Originalsprache)
Objective
The purpose of this study was to examine how the radiopharmaceutical accumulation in the brain changes with the elapsed time between the administration of 18 F-flutemetamol and the start of imaging, and to determine its effect on quantitative indices.
Methods
The study population consisted of 25 subjects who agreed to participate in the study. After visual evaluation by the radiologist, 14 subjects tested negative for Aβ accumulation, and 11 subjects tested positive as well. The study population was treated with 18 F-flutemeamol, and list mode acquisition was performed for 50 min starting at 60 min after the time of administration. From the acquired list data, five PET images were extracted at 10-min intervals from the start to the end of acquisition, a PET image corresponding to 20 min of acquisition from 60 min after administration, and a PET image corresponding to 20 min of acquisition from 90 min after administration, respectively. Pixel values were measured for the PET images created and quantitative indices (pixel value, SUVr, Centiloid scale) were calculated and compared.
Results
In most of the PET images, pixel values showed a decreasing trend with elapsed time after radiopharmaceutical administration. Accordingly, calculated SUVr and Centiloid Scale also changed.
Conclusions
Elapsed time after radiopharmaceutical administration resulted in a washout of the radiopharmaceutical accumulation in the brain. From this, it was suggested that the quantitative indices change.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Juntendo University Hospital, 3‑1‑3, Hongo, Bunkyo‑ku, Tokyo, 113‑8421, Japan. stakemot@juntendo.ac.jp.
- Department of Radiology, Juntendo Tokyo Koto Geriatric Medical Center, 3‑3‑20, Shinsuna, Koto‑ku, Tokyo, 136‑0075, Japan.
- Department of Radiology, Juntendo University Hospital, 3‑1‑3, Hongo, Bunkyo‑ku, Tokyo, 113‑8421, Japan.
- Department of Neurology, Juntendo University Hospital, 3‑1‑3, Hongo, Bunkyo‑ku, Tokyo, 113‑8421, Japan.
Förderung
- Nihon Medi-Physics
Zitieren
APA
Takemoto, S., Onuki, K., Tanimoto, K., Taniguchi, M., Suero, T., Okamoto, M., Kimura, S., Osawa, M., Takeshige-Amano, H., Nishikawa, N., Aoki, S., Kuwatsuru, R., Hattori, N., & Murakami, K. (2025). Elapsed time changes of the brain radiopharmaceutical accumulation of the amyloid PET examination using 18F-flutemetamol. Annals of Nuclear Medicine. https://doi.org/10.1007/s12149-025-02046-3
Vancouver
Takemoto S, Onuki K, Tanimoto K, Taniguchi M, Suero T, Okamoto M, et al. Elapsed time changes of the brain radiopharmaceutical accumulation of the amyloid PET examination using 18F-flutemetamol. Annals of Nuclear Medicine. 2025. doi:10.1007/s12149-025-02046-3
BibTeX
@article{Takemoto2025,
author = {Takemoto, Shota and Onuki, Koji and Tanimoto, Keiko and Taniguchi, Masaho and Suero, Takako and Okamoto, Mio and Kimura, Satoshi and Osawa, Monami and Takeshige-Amano, Haruka and Nishikawa, Noriko and Aoki, Shigeki and Kuwatsuru, Ryohei and Hattori, Nobutaka and Murakami, Koji},
title = {Elapsed time changes of the brain radiopharmaceutical accumulation of the amyloid PET examination using 18F-flutemetamol},
journal = {Annals of Nuclear Medicine},
year = {2025},
doi = {10.1007/s12149-025-02046-3}
}
EUVIMED